Skip to content

Pfizer PFE Treasury Stock

Treasury Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.52B-0.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$75.86B+0.2%
Merck & Co. logo
Merck & Co.MRK
$63.75B+7.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$405.78M+25.5%
Viatris logo
ViatrisVTRS
$1.01B+48.1%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$139.86B+1.2%
Enterprise value$202.53B+2.2%
P/E11.6×
P/S2.2×0.0×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's treasury stock?
Pfizer (PFE) reported treasury stock of $115.19B in Q1 2026.
How has Pfizer's treasury stock changed year-over-year?
Pfizer's treasury stock increased by 0.2% year-over-year, from $115.01B to $115.19B.
What is the long-term trend for Pfizer's treasury stock?
Over 5 years (2020 to 2025), Pfizer's treasury stock has grown at a 0.7% compound annual growth rate (CAGR), from $110.99B to $115.02B.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.